Monitoring the degradation capability of novel haloalkaliphilic tributyltin chloride (TBTCl) resistant bacteria from butyltin-polluted site

Isolation and Characterization a Novel Catabolic Gene Cluster Involved in Chlorobenzene Degradation in Haloalkaliphilic Alcanivorax sp. HA03

Chlorobenzene (CB) poses a serious risk to human health and the environment, and because of its low degradation rate by microorganisms, it persists in the environment. Some bacterial strains can use CB as growth substrates and their degradative pathways have evolved; very little is known about these pathways and the enzymes for CB degradation in high pH and salinity environments. Alcanivorax sp. HA03 was isolated from the extremely saline and alkaline site. HA03 has the capability to degrade benzene, toluene and chlorobenzene (CB). CB catabolic genes were isolated from HA03, which have a complete gene cluster comprising α and β subunits, ferredoxin and ferredoxin reductase (CBA1A2A3A4), as well as one gene-encoding enzyme for chlorocatechol 1,2-dioxygenase (CC12DOs). Based on the deduced amino acid sequence homology, the gene cluster was thought to be responsible for the upper and lower catabolic pathways of CB degradation. The CBA1A2A3A4 genes probably encoding a chlorobenzene dioxygenase was confirmed by expression during the growth on CB by RT-PCR. Heterologous expression revealed that CBA1A2A3A4 exhibited activity for CB transformation into 3-chlorocatechol, while CC12DOs catalyze 3-chlorocatechol, transforming it into 2-chloromucounate. SDS-PAGE analysis indicated that the sizes of CbA1 and (CC12DOs) gene products were 51.8, 27.5 kDa, respectively. Thus, Alcanivorax sp. HA03 constitutes the first bacterial strain described in the metabolic pathway of CB degradation under high pH and salinity conditions. This finding may have obvious potential for the bioremediation of CB in both highly saline and alkaline contaminated sites.

Trends in microbial degradation and bioremediation of emerging contaminants

Modernization and modern ways of living demands more improved products from pharmaceuticals, cosmetics, and food processing industries. Moreover, industries like pesticides, fertilizers, dyeing, paints, detergent etc., also needs improvised products as per demand. As the new product emerges, the pollutants from these industries also constitute new type of danger to the environment and serious health risks to the living organisms. These emerging contaminants (ECs) are from different category of sources such as personal care products (PCPs), pharmaceuticals (Phcs), endocrine disrupting chemicals (EDCs), etc. These ECs can easily escape from the conventional water treatment and eventually get discharged in to the surface water and thus enters in to the ground water, soil, sediments, and also into the oceans. When these contaminants emerge we also require progress in tremendous process for preventing these hazardous chemicals by effective removal and treatment. For the past 50 years, both developed and developing countries are working on this treatment process and found that Microbial degradation and bioremediation are very useful for effective treatment to prevent their emissions. This treatment can be designed for any sort of ECs since the microbial members are so versatile to redesign their metabolic pathways when subject to exposure. However, implementing bioremediation is not alone efficient to degrade ECs and hence, combination of bioremediation, nanotechnology and physical treatment method will also provide sustainable, potent and fast degradation process. In this Book Chapter, we discuss in detail about the ECs, sources of microbial degradation process and its usefulness in the bioremediation of these ECs.